Yes. CDC states that people ages 6 months and older who are moderately or severely immunocompromised have the option to receive 1 additional dose of COVID-19 vaccine at least 2 months following the last recommended 2023–2024 Formula COVID-19 vaccine dose. Further additional dose(s) may be administered, informed by the clinical judgement of the healthcare provider and personal preference and circumstances. Any further additional doses should be administered at least 2 months after the last 2023–2024 COVID-19 vaccine dose.
To evaluate an immunocompromised individual’s COVID-19 vaccine needs based upon the person’s age and COVID-19 vaccination history, use this infographic from CDC: www.cdc.gov/vaccines/covid-19/downloads/COVID19-vaccination-recommendations-immunocompromised.pdf.